Brief: Relay Therapeutics Q4 Net Income USD -54.889 Million Vs. IBES Estimate USD -68.1 Million
26/02/2026 21:05
Feb 26 (Reuters) - Relay Therapeutics Q4 revenue USD 7 million vs. IBES estimate USD 4.97 million. Q4 basic EPS USD -0.32 Q4 operating expenses USD 67.63 million Q4 operating income USD -60.63 million Q4 EPS USD -0.32
Recent news on Relay Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Moderna, Kontoor Brands, Ralph Lauren
U.S. STOCKS ON THE MOVE- Intuit, Deere, Advance Auto Parts
U.S. STOCKS ON THE MOVE-Keysight Technologies, Relay Therapeutics, Ralph Lauren
Relay Therapeutics gains after $275 mln equity raise
Brief: Relay Therapeutics Announces Pricing Of Public Offering Of Common Stock